CorMedix (CRMD) Change in Account Payables (2010 - 2025)

CorMedix has disclosed Change in Account Payables across 14 years of filings, most recently posting -$7.3 million for Q4 2025.

• Change in Account Payables for Q4 2025 came in at -$7.3 million, down 2033.02% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.3 million (up 230.04% YoY), and the FY2025 annual result was $3.3 million, up 230.04% from the prior year.
• Change in Account Payables came in at -$7.3 million for Q4 2025 at CorMedix, down from $6.5 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $6.5 million in Q3 2025 to a low of -$7.3 million in Q4 2025.
• The 4-year median for Change in Account Payables is $375851.0 (2024), against an average of $252402.5.
• Peak annual rise in Change in Account Payables reached 648.76% in 2025, while the deepest fall reached 2033.02% in 2025.
• CorMedix's Change in Account Payables stood at $434753.0 in 2022, then jumped by 335.55% to $1.9 million in 2023, then plunged by 80.15% to $375851.0 in 2024, then slumped by 2033.02% to -$7.3 million in 2025.
• The last three Change in Account Payables figures came in at -$7.3 million (Q4 2025), $6.5 million (Q3 2025), and $3.9 million (Q2 2025), per Business Quant data.